Join our webinar to discover the underpinnings of successful Procalcitonin (PCT) testing implementation in emergency departments and general wards and how this leads to improved patient outcomes. Delayed targeted therapy or inadequate therapy increases the risk of adverse patient outcomes and prolonged hospital stays and increased emergency department crowding.
In this presentation Dr. Joshua Hayden will discuss essential topics of PCT implementation such as assay selection, validation, and standardization of Procalcitonin testing.
Dr. Jim Neuenschwander will examine accelerating treatment decisions and therapy in the emergency department with B·R·A·H·M·S PCT. Dr. Neuenschwander will also discuss transition of care from emergency department to the in-patient setting.
Learning Objectives:
1. Summarize the role of Procalcitonin in the management of sepsis, lower respiratory tract infections and undifferentiated shortness of breath
2. Compare and contrast available Procalcitonin assays, understanding their differences and applications
3. Gain insight into how PCT improves outcomes of infected emergency patients, especially elderly or at-risk